title: Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
abstract: Vaginal dryness is a common condition that is particularly prevalent during and after the menopause, and is one of the symptoms of vulvovaginal atrophy/genitourinary syndrome of menopause. The impact of vaginal dryness on interpersonal relationships, quality of life, daily activities, and sexual function can be significant, but is frequently underestimated. Furthermore, barriers exist to treatment-seeking, and this condition is often underreported and undertreated. Greater education about vaginal dryness and the range of available treatments is essential to encourage more women to seek help for this condition. Personal lubricants and moisturizers are effective at relieving discomfort and pain during sexual intercourse for women with mild to moderate vaginal dryness, particularly those who have a genuine contraindication to estrogen, or who choose not to use estrogen. However, there is a distinction between lubricants and moisturizers, and notable differences between commercially available products. Women should be advised to choose a product that is optimally balanced in terms of both osmolality and pH, and is physiologically most similar to natural vaginal secretions. A series of recommendations for the use of vaginal lubricants and moisturizers, either on their own or in combination with systemic or topical hormone replacement therapy, is presented.
authors.affiliation: a Claridges Barn , Charlbury Road, Chipping Norton , Oxon , UK ;
authors.forename: D
authors.initials: D
authors.lastname: Edwards
authors.affiliation: b Queen Charlotte's & Chelsea Hospital and Chelsea & Westminster Hospital, and Honorary Senior Lecturer, Imperial College , London , UK.
authors.forename: N
authors.initials: N
authors.lastname: Panay
mesh_terms: D000282:Administration, Intravaginal; D001284:Atrophy; D004414:Dyspareunia / Q000188:drug therapy / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D006801:Humans; D054327:Lubricants / Q000008:administration & dosage*; D008593:Menopause; D011788:Quality of Life; D014621:Vagina / Q000473:pathology; D014623:Vaginal Diseases / Q000188:drug therapy* / Q000473:pathology; D014844:Vulva / Q000473:pathology; D016387:Women's Health
chemical_list: D054327:Lubricants
keywords: Cytotoxicity; genitourinary syndrome of menopause; lubricant; moisturizer; osmolality; vaginal dryness; vulvovaginal atrophy